LEGAL NEWS
Federal marshals seized more than 1,600 containers from a Missouri distributor last week, alleging that the drugs were unapproved by FDA and misbranded. » More
|
PBM NEWS
The Federal Trade Commission approved the $29.1 billion merger of Express Scripts and Medco Health Solutions on Monday, but the retail pharmacy industry continues to fight the deal after filing a temporary restraining order Friday. » More
|
|
Should independent pharmacies be given anti-trust immunity to act against contracts presented by pharmacy benefit managers? A representative of the Federal Trade Commission said “no” and pharmacists said “yes” during a Congressional subcommittee hearing on HR 1946 last week. » More
|
CONTINUING EDUCATION
Of the 35 new molecular entities approved by FDA in 2011, 17 are considered groundbreaking because of their potential to make a real difference in the lives of patients.
To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to login.
|
GENERICS NEWS
Teva Pharmaceutical has launched the authorized generic of Provigil (modafinil), a drug marketed as a wakefulness-promoting agent used to treat sleep disorders, the company announced. » More
|
CLINICAL NEWS
New guidelines for management of hand, hip, and knee osteoarthritis were published in the April edition of Arthritis Care & Research. » More
|
CHAINS AND BUSINESS
In an extension of its health tours for underserved communities, Walgreens recently started the Way to Well Health Tour with AARP. » More
|
Survey
a) Yes, my employer allows PharmD after my name or the use of the title Dr. before my name.
b) Yes, my employer allows PharmD after my name but not the title Dr. before my name.
c) No, my employer does not allow any doctor title before or after my name.
Respond here and see what your colleagues think, too.
Want to see the results of our last survey about whether pharmacists should have the authority to prescribe medications? Click here.
|
|
Digital Edition |
|
|
|
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To ensure delivery to your inbox, please add us to your address book. If you need help doing this, Click here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 866-529-2922 at any time, or
fax us at 218-740-6417. Outside the U.S., please phone 218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
|
|
|
